Introduction {#Sec1}
============

*Aedes aegypti* is the primary vector of a growing list of pathogenic viruses that cause disease in humans including dengue virus (DENV). DENV infection leads to multiple clinical manifestations ranging from a febrile illness called dengue fever to severe dengue, which can include septic shock^[@CR1],[@CR2]^. There are no targeted antiviral therapies for DENV and use of a conventional vaccine may risk causing antibody-dependent enhancement of DENV or a related pathogenic flavivirus^[@CR3]^. It is theoretically possible to target vector proteins or cellular pathways as a method to interfere with the flavivirus transmission cycle^[@CR3]--[@CR11]^. This strategy requires identification of proteins or cellular pathways that modify flavivirus acquisition or transmission.

Flavivirus acquisition in the mosquito begins when the mosquito engorges on the blood of an infected vertebrate host. Virions establish infection of midgut epithelial cells and infection leads to widespread transcriptomic and proteomic alterations^[@CR4],[@CR12]^. We hypothesized that flavivirus infection alters the mosquito cell secretome -- the proteins and peptides that are secreted into the extracellular milieu and play important pathological and physiological roles. Characterizing the secretome can identify key proteins and cellular pathways that are modified during infection and reveal new therapeutic targets^[@CR13]--[@CR15]^.

Here we find that DENV infection of *Ae. aegypti* cells leads to accumulation of extracellular fragments of low-density lipoprotein receptor-related protein 1 (LRP-1). LRP-1 belongs to a group of cell surface proteins that can undergo regulated intramembrane proteolysis (RIP) upon ligand binding in a Notch-like fashion. LRP-1 proteolysis leads to the release of both intracellular and extracellular domains. The intracellular domain mediates signal transduction. The role of the soluble extracellular domain is less clear^[@CR16]^.

Previous literature suggests that LRP-1 is a multifunctional cell surface receptor with diverse physiological roles ranging from cellular uptake of lipoproteins and other cargo to promoting cholesterol export and inhibiting accumulation of intracellular cholesterol^[@CR17]--[@CR24]^. LRP-1 deficiency has led to intracellular lipid accumulation in a number of experimental models^[@CR17]--[@CR24]^. In the context of cytomegalovirus (CMV) infection, LRP-1 inhibits virion infectivity by depleting intracellular cholesterol, which limits the amount of cholesterol in the viral envelope^[@CR25]^. We hypothesized that DENV infection modifies LRP-1 protein expression, which increases host-derived intracellular cholesterol - a requirement for synthesis of intracellular membrane replication compartments.

Materials and Methods {#Sec2}
=====================

Cell culture and virus production {#Sec3}
---------------------------------

Two *Aedes spp*. cell lines were used in this study, Aag2 and C6/36 cells. The *Ae. aegypti* cell line, Aag2 (ATCC, VA), was used for *in vitro* studies. Aag2 cells were grown at 28 °C with 5% CO2 in Schneider's Drosophila Medium for transfection studies and DMEM high glucose media for the remaining studies. Both types of media were supplemented with 10% heat-inactivated fetal bovine serum (Gemini, CA), 1% penicillin-streptomycin, and 1% tryptose phosphate broth (Sigma, MO). Lipid-depleted serum was made by incubating serum with fumed silica overnight followed by removal of silica-lipid complexes by centrifugation^[@CR26]^. Lipid-depleted serum was added to cell culture components to make lipid-depleted media. In addition, the *Ae. albopictus* cell line, C6/36 (obtained from Erol Fikrig), was used to grow DENV stocks using the same media. The dengue strain used was DENV-2 New Guinea C. C6/36 cells were infected at an MOI of 1.0 virus stock was stored at −80 °C until use.

LC + MS/MS {#Sec4}
----------

Cell free supernatants were taken from mock and DENV2-infected Aag2 cells at 1 and 7 dpi and submitted to the Interdisciplinary Center for Biotechnology Research at the University of Florida for liquid chromatography tandem mass spectrometry (LC + MS/MS). Charge state deconvolution and deisotoping were not performed. All MS/MS samples were analyzed using Mascot. Mascot was set up to search the Aedesaegypti_201505 database (selected for *Aedes aegypti*, unknown version, 37,800 entries) assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of 0.050 Da and a parent ion tolerance of 10.0 PPM. Carbamidomethyl of cysteine was specified in Mascot as a fixed modification. Gln- \> pyro-Glu of the n-terminus, deamidated of asparagine and glutamine and oxidation of methionine were specified in Mascot as variable modifications. Scaffold (version Scaffold_4.4.8, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 50.0% probability by the Peptide Prophet algorithm with Scaffold delta-mass correction. Protein identifications were accepted if they could be established at greater than 50.0% probability and contained at least 1 identified peptide. Protein probabilities were assigned by the Protein Prophet algorithm.

qRT-PCR-based assays {#Sec5}
--------------------

RNA from Aag2 cells was isolated using RNeasy kit (Qiagen, CA) following the manufacturer's instructions and RNA was kept at −20 °C until testing. The qRT-PCR assay was done using the QuantiFast kit according to the manufacturer's instructions (Qiagen, CA). Oligos for the qRT-PCR reactions were: DENV-2 envelope (E) protein: F: 5′-CATTCCAAGTGAGAATCTCTTTGTCA-3′ R: 5′-CAGATCTCTGATGAATAACCAACG-3′; *Ae. aegypti* Actin: F: 5′-GAACACCCAGTCCTGCTGACA-3′, R: 5′-TGCGTCATCTTCTCACGGTTAG-3′. *Ae. aegypti* LRP-1: 5′-3′ F: 5′-GAAACAACCGGAAACAGCTCACCCATGTCG-3′ R: 5′-GATCCCCAGTGGAATGCCTCGGATCATGCC-3′. Viral RNA or LRP-1 expression was normalized to either total cellular RNA or actin expression. Each sample was tested in duplicate.

dsRNA production and transfection {#Sec6}
---------------------------------

For gene knockdown, dsRNA was produced from approximately 500 bp coding regions of either *Ae. aegypti* LRP-1 (VectorBase: AAEL007041, GenBank: EAT41289) or green fluorescent protein (GFP) as a control. Briefly, PCR was used to produce a DNA template with T7 overhangs that was then used with the Ambion Megascript kit according to manufacturer's instructions to produce the dsRNA molecules. Oligos used for making dsRNA are as follows: GFP: F: 5′-TAATACGACTCACTATAGGGAGAGATGCCACCTACGGCAAGC-3′ R: 5′-TAATACGACTCACTATAGGGAGAGACAGGTAGTGGTTATCGGG-3′LRP-1: F: 5′-TAATACGACTCACTATAGGGAGAatcgacgtttcggacgaagacgcggacc-3′R: 5′-TAATACGACTCACTATAGGGAGATTAATGCTAGGTGAGTGTTCGTgttggttac-3′. The dsRNA molecules were transfected into cells using Lipofectamine 2000 (ThermoFisher) according to manufacturer's instructions.

Intracellular cholesterol content {#Sec7}
---------------------------------

Total intracellular cholesterol was measured using the Amplex Red Cholesterol Assay Kit (Invitrogen). Aag2 cells were lysed in PBS containing 1% Triton X-100 and protease inhibitor cocktail. 2 ug of total protein was used for each sample. The reactions were brought up to a total reaction volume of 50 ul using 1x reaction buffer from the kit and applied to individual wells on a 96-well microplate. 50 ul of Amplex Red reagent/HRP/cholesterol oxidase/cholesterol esterase working solution was added to each well and the plate was incubated at 37 °C for 30 minutes protected from light. The fluorescence was measured using a Tecan Infinite M200 Pro microplate reader using excitation at 550 nm and emission detection at 590 nm.

Western blot {#Sec8}
------------

Aag2 cells were lysed using RIPA buffer containing a protease inhibitor cocktail (Sigma). Protein concentration was determined using a BCA assay. 9 µg of total protein from each sample was separated by a SDS-PAGE gel (5--9%) and transferred to a nitrocellulose membrane. Membranes were blocked with 5% non-fat dry milk at room temperature for 1 hour prior to overnight incubation at 4 °C with primary antibody anti-LRP1 (cat. no. ab 92544, 1:20000, Abcam) and anti-actin antibody (cat. No. SC-1615, 1:1000, Santa Cruz Biotechnology) as a loading control. The membranes were washed with PBST and incubated at room temperature for 1 hour with anti-rabbit IgG-HRP (cat. no. 70745, 1:2000, Cell Signaling Technology) and anti-goat IgG-HRP linked (cat. no. ab6741, 1:2000, Abcam) secondary antibodies. Signal was detected using a ChemiDoc Touch Imaging System by Biorad.

Focus-forming unit assay {#Sec9}
------------------------

Aag2 cells were fed with complete or lipid-depleted media for 7 days and then inoculated with 50 focus-forming units of DENV2 in complete media. Unbound virus was removed after one hour and complete media was added. Confluent monolayers were fixed with 4% paraformaldehyde and stained with 1:200 anti-DENV2 envelope antibody (3H5-1, EMD Millipore) 3 days post-infection and the total number of flavivirus positive foci were counted per well. Flavivirus positive foci were revealed using a 1:2000 horseradish peroxidase-conjugated secondary antibody and a Vectastain ABC kit immunocytochemistry kit. Digital images were taken using an Evos Core inverted microscope.

Results {#Sec10}
=======

Alterations of the Aag2 secretome during DENV infection {#Sec11}
-------------------------------------------------------

We hypothesized that DENV infection would alter the secretome of mosquito cells. To test this hypothesis, we first confirmed previous results that the *Ae. aegypti* Aag2 cell line was permissive to DENV2 infection by inoculating cells with or without 1 × 10^6^ genome equivalents of DENV2 New Guinea Strain C. Cells were fixed 7 days post infection (dpi) and stained with an anti-DENV2 envelope monoclonal antibody and secondary antibody conjugated with Alexa Fluor 488. Aag2 cells were highly permissible to infection and DENV2 envelope protein was observed in almost every cell (Fig. [1](#Fig1){ref-type="fig"}). Aag2 cells were then inoculated with approximately 1 × 10^6^ genomic equivalents of DENV2 for 1 hr, unbound virus was removed, and fresh media was added. Mock-infected controls were included. Cell-free supernatants were collected 1 and 7 dpi and submitted for liquid chromatography tandem mass spectrometry (LC + MS/MS) to detect the proteins in the secretome. We identified a total of 239 and 120 proteins in mock and DENV2-infected supernatants at 1 dpi, respectively. We identified a total of 183 and 136 proteins in mock and DENV2-infected supernatants at 7 dpi, respectively. The majority of proteins detected during infection were unique compared to mock infected samples. Approximately 80% of proteins detected in DENV-infected Aag2 cell supernatants were not identified in mock-infected supernatants at 1 or 7 dpi (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, Fig. [2A](#Fig2){ref-type="fig"}). Only 6 proteins were detected in DENV2-infected Aag2 cell supernatants but not mock-infected supernatants at both 1 and 7 dpi (Table [3](#Tab3){ref-type="table"}, Fig. [2A](#Fig2){ref-type="fig"}).Figure 1Immunocytochemistry of DENV2-infected Aag2 cells. Aag2 cells were grown in glass chambers and were inoculated with virus free (Mock) or DENV2-infected cell culture media and then fixed 7 dpi. Fixed cells were incubated with anti-DENV2 E antibody followed by a secondary antibody containing a fluorophore (green). Cell nuclei were counterstained with DAPI. Images were taken at 100x magnification.Table 1LC + MS/MS hits specific to DENV2-infected AaG2 cell supernatant 1 dpi.IdentifierCommentAAEL009437N/AAAEL012951transformation/transcription domain-associated proteinAAEL007132dynein heavy chainAAEL007041low density lipoprotein receptor (ldl)AAEL012437N/AAAEL000981N/AAAEL007158nnp-1 protein (novel nuclear protein 1) (nop52)AAEL010871N/AAAEL000430N/AAAEL000895peroxisome biogenesis factor 1 (peroxin-1)AAEL004699N/AAAEL009431mitochondrial ribosomal protein, L10, putativeAAEL011239short-chain dehydrogenaseAAEL005240rabaptin-5, putativeAAEL013174N/AAAEL013060N/AAAEL008220N/AAAEL017221odorant receptorgi\|167515086sodium-dependent nutrient amino acid transporter 8AAEL007980N/AAAEL011526GPCR Methuselah FamilyAAEL003575N/AAAEL000589serine/threonine protein kinaseAAEL001607galactose-1-phosphate uridylyltransferaseAAEL011693mitotic control protein dis3AAEL010459N/AAAEL011810N/AAAEL009382lysine-specific demethylase NO66AAEL006340N/AAAEL000645N/AAAEL009477N/AAAEL015352lachesin, putativeAAEL006765N/AAAEL003020tailless (tll)AAEL012825bifunctional purine biosynthesis proteinAAEL005319myosin light chain kinaseAAEL001796nuclear hormone receptor (HR78)AAEL006708hedgehogAAEL010693N/AAAEL004064meiotic checkpoint regulator cut4AAEL00250826S protease regulatory subunit 6aAAEL001716THO complex subunit 2 (Tho2)AAEL002544N/AAAEL006352N/AAAEL002628N/AAAEL004600N/AAAEL003168N/AAAEL011965nuclear lamin L1 alpha, putativeAAEL014144rapsynoidAAEL006247N/AAAEL001442map-kinase activating death domain proteinAAEL012744N/AAAEL013473cAMP-specific 3,5-cyclic phosphodiesteraseAAEL000596myosinAAEL004376N/AAAEL013466ankyrin 2,3/unc44AAEL009159nervous wreck, putativeAAEL009847microtubule-associated proteinAAEL001582kinesinAAEL007079N/AAAEL006958cell adhesion moleculeAAEL004299angiotensin-converting-relatedenzymeAAEL002896N/AAAEL014296major sperm proteinAAEL008559glutaminaseAAEL012158WD repeat-containing protein 48AAEL003008N/AAAEL007857N/AAAEL008610myosin viiAAEL005681GPCR Histamine FamilyAAEL006187translational activator gcn1AAEL009878N/AAAEL009019N/AAAEL012072histone H3AAEL009762cytochrome P450AAEL003641sodium/chloride dependent amino acid transporterAAEL001598N/AAAEL006806N/AAAEL011187U520AAEL015365N/AAAEL008591zinc finger protein, putativeAAEL004644N/AAAEL008704N/AAAEL010473NAD dependent epimerase/dehydrataseAAEL008365N/AAAEL014885N/Agi\|70907192N/AAAEL013903gamma-tubulin complex component 2 (gcp-2)AAEL009480N/AAAEL009152N/AAAEL006050nuclear RNA export factor 2 (NXF2), putativeAAEL003229N/AAAEL009049N/AAAEL000489P21-activated kinase, pakAAEL014315N/AAAEL010575dimethyladenosine transferaseAAEL004049N/AAAEL017063gustatory receptor Gr32AAEL007565leucine rich protein, putativeAAEL006394N/AAAEL002814N/AAAEL015467segmentation protein cap'n'collarAAEL002256collagen alpha 1(xviii) chainAAEL012774protease m1 zinc metalloproteaseAAEL002850patched 1AAEL000318N/AAAEL000168N/AAAEL011566cell adhesion moleculeAAEL001773N/AAAEL004320WOC protein, putativeAAEL007400signal recognition particle 54 kda proteinAAEL006067N/AAAEL012483N/AAAEL014664AMP dependent coa ligaseAAEL003829dynaminAAEL001113inorganic phosphate cotransporter, putativeAAEL013085N/AAAEL011231N/AAAEL010765N/AAAEL010308N/ATable 2LC + MS/MS hits specific to DENV2-infected AaG2 cell supernatant 7 dpi.IdentifierCommentAAEL008845N/AAAEL001454N/AAAEL004179N/AAAEL007225dynein heavy chainAAEL011083N/AAAEL007132dynein heavy chainAAEL013943mediator complex, 100kD-subunit, putativeAAEL015065spectrinAAEL013690DNA mismatch repair protein pms2AAEL006309N/AAAEL006374N/AAAEL006954N/AAAEL008154N/AAAEL000510N/AAAEL011103centromere/kinetochore protein zw10AAEL010342racGTPase-activating proteinAAEL007099environmental stress-induced protein, putativeAAEL011433small nuclear ribonucleoprotein sm d3AAEL009220N/AAAEL001581N/AAAEL000608N/AAAEL008318cadherin, putativegi\|167651374phosphoglycerate kinase, partialAAEL011178posterior sex combs proteinAAEL005881autocrine motility factor receptor, amfrAAEL002101N/AAAEL012446Inhibitor of Apoptosis (IAP) containing Baculoviral IAP Repeat(s)AAEL012338N/AAAEL003044fasciclin-1 precursorAAEL013593N/AAAEL009660N/AAAEL009839nuclear cap-binding protein subunit 1AAEL001921N/AAAEL001201N/AAAEL009308WD-repeat proteinAAEL012587N/AAAEL013227PIWIAAEL002782N/AAAEL001357N/AAAEL006790N/AAAEL002250terminal deoxycytidyl transferase rev1AAEL004834PHD finger proteinAAEL008670protein taraAAEL006082transcription initiation factor TFIID subunit 1AAEL010336zinc phosphodiesteraseAAEL005211microtubule associated-protein orbitAAEL000668N/AAAEL002551DNA topoisomerase type IAAEL005284receptor tyrosine phosphatase type r2aAAEL003739M-type 9 protein, putativeAAEL008573zinc finger proteinAAEL006339peptidylglycine alpha-amidating monooxygenase C-terminal protein-1AAEL002670AMP dependent ligaseAAEL006808N/AAAEL002070N/AAAEL013110N/AAAEL005381dissatisfaction (Dsf)AAEL001438N/AAAEL011052N/AAAEL004017DNA polymerase vAAEL015631asparagine synthetaseAAEL014138serine protease inhibitor (serpin)AAEL005450N/AAAEL003105supervillinAAEL000007N/AAAEL000596myosinAAEL010061N/AAAEL007111N/AAAEL001411myosin heavy chain, nonmuscle or smooth muscleAAEL012331N/AAAEL005484sorting nexinAAEL013534tgf-beta resistance-associated protein tragAAEL005180N/AAAEL014995ornithine decarboxylaseAAEL013559uncoordinated proteinAAEL013561N/AAAEL004839cyclin tAAEL013635N/AAAEL005949beta-1,2-n-acetylglucosaminyltransferase iiAAEL004136N/AAAEL009164tRNA delta(2)-isopentenylpyrophosphate transferaseAAEL004219rap GTPase-activating proteinAAEL010940N/AAAEL010916N/AAAEL009673GPCR Gonadotrophin Releasing Hormone FamilyAAEL010101N/AAAEL007041low density lipoprotein receptor (ldl)AAEL013999N/AAAEL007447N/Agi\|90655947female specific 1 proteinAAEL011551N/AAAEL009958N/AAAEL005101carboxy/choline esterase alpha esteraseAAEL008943chromatin assembly factor 1, p180-subunit, putativeAAEL012223zinc finger proteinAAEL008462apl5 proteinAAEL003939eukaryotic translation initiation factor 2-alpha kinase 3AAEL010341RuvB-like helicase 2AAEL000912N/AAAEL004854N/AAAEL001375Y-box binding proteinAAEL005461N/AAAEL002357N/AAAEL008358ablimAAEL002833cathepsin lAAEL012412slit proteinAAEL007820N/AAAEL000423N/AAAEL011791N/AAAEL008653engulfment and cell motility proteinAAEL004917N/AAAEL001649leucine aminopeptidaseAAEL002922glutamate receptor 7AAEL008929C-Type Lectin (CTL)AAEL0022165-AMP-activated protein kinase, beta subunitgi\|94468626C2H2-type Zn-finger proteinAAEL007042far upstream (fuse) binding proteinAAEL003345argininosuccinate lyaseAAEL015537N/AAAEL001773N/AAAEL004196galectinAAEL009415synembrynAAEL013404tetraspaninAAEL011570acidic fibroblast growth factor intracellular binding proteinAAEL000854fumarylacetoacetate hydrolaseAAEL013729myotonin-protein kinaseAAEL004880N/AAAEL004471N/AAAEL013174N/AAAEL002544N/AAAEL008075N/AAAEL002485WD repeat-containing protein on Y chromosome (WD40 Y)AAEL006156N/AAAEL013135chromodomain helicase DNA binding proteinAAEL000922polyribonucleotide nucleotidyltransferaseAAEL001311N/AFigure 2DENV2 infection induces shedding of LRP-1 peptides in Aag2 cells. (**A**) Venn diagram showing DENV2-specific proteins in the Aag2 secretome that were identified by LC + MS/MS 1 and 7 dpi. (**B**) qRT-PCR analysis of DENV2 viral RNA (vRNA) in cell culture supernatant in Mock and DENV2-infected cells 1 and 7 dpi. vRNA levels were normalized to total ng cellular RNA extracted from the cells in each well. (**C**) qRT-PCR analysis of LRP-1 mRNA in Mock and DENV2-infected cells 1 and 7 dpi. vRNA levels were normalized to total ng cellular RNA extracted from the cells in each well. (**D**) Western blot analysis of LRP-1 and actin in Aag2 cell lysates made from Mock and DENV2-infected cells 7 dpi.Table 3LC + MS/MS hits specific to DENV2-infected AaG2 cell supernatants 1 dpi and 7 dpi.IdentifierCommentAAEL007132dynein heavy chainAAEL000596myosinAAEL007041low density lipoprotein receptor (ldl)AAEL013174N/AAAEL002544N/AAAEL001773N/A

We chose to investigate the six proteins found in DENV2-infected Aag2 cell supernatants at both 1 and 7 dpi. Three of the proteins (SeqIDs, AAEL013174, AAEL002544, and AAEL01773) lacked homology to any known protein and lacked predicted signal peptides according to SignalP4.1 and were eliminated from further analysis. The remaining three proteins were annotated as dynein heavy chain (AAEL007132), myosin (AAEL000596), and low-density lipoprotein receptor (ldl) (AAEL007041). Although each of these proteins also lacked signal peptides according to SignalP4.1, previous literature has characterized protein-protein interactions between dynein heavy chain and myosin with flavivirus structural proteins suggesting that these proteins may end up in the supernatant during shedding of progeny virions or through secretion of exosomes^[@CR27]^. We therefore chose to further investigate the role of AAEL007041 in DENV infection.

DENV infection reduces LRP-1 protein expression {#Sec12}
-----------------------------------------------

Despite its annotation, BLAST analysis of AAEL007041 revealed that this protein is homologous to low-density lipoprotein receptor-related protein 1 (LRP-1) rather than low-density lipoprotein receptor (LDLR). LRP-1 belongs to a group of cell surface proteins that can undergo regulated intramembrane proteolysis (RIP) upon ligand binding in a Notch-like fashion. LRP-1 proteolysis leads to the release of both intracellular and extracellular domains^[@CR16]^. Additionally, LRP-1 has been identified as a factor that reduces accumulation of intracellular cholesterol^[@CR17],[@CR18],[@CR21]--[@CR25]^. We hypothesized that DENV infection modifies LRP-1 protein expression, which would impact intracellular cholesterol levels. We first confirmed that the two LRP-1 peptides we detected by LC + MS/MS resided in the approximately 500 kDa extracellular domain. Both peptides (i.e, CVGIDNFLMYSIGHQLK and ADYDGRNRV) were located in the 500 kDa extracellular domain of LRP-1. We then determined if LRP-1 expression is altered at the transcriptional level. DENV infection did not alter LRP-1 gene expression 1 or 7 dpi (Fig. [2B,C](#Fig2){ref-type="fig"}). Our result is consistent with previously published RNASeq data that determined the impact of DENV infection on gene expression in *Ae. aegypti* carcass, midgut, and salivary gland tissue^[@CR12]^. In contrast, Western blot analysis using a monoclonal antibody against an evolutionarily conserved epitope in the 85 kDa intracellular LRP-1 domain revealed that DENV2 infection reduced LRP-1 protein expression (Fig. [2D](#Fig2){ref-type="fig"}). These results indicate that DENV infection reduces LRP-1 protein expression while increasing peptides that correspond to LRP-1's extracellular domain.

Diverse stimuli reduce LRP-1 protein expression in mosquito cells {#Sec13}
-----------------------------------------------------------------

Previous research identified a number of physiologic stimuli that can reduce LRP-protein expression, and this process often occurs through RIP. Both reactive oxygen species and cholesterol depletion can reduce LRP-1 protein expression^[@CR19],[@CR28]--[@CR32]^. Flavivirus infection is known to lead to the production of reactive oxygen species and it modifies intracellular cholesterol^[@CR33]--[@CR37]^. We determined if reactive oxygen species and lipid depletion could reduce LRP-1 protein expression in Aag2 cells. Hydrogen peroxide was used as a prototypical reactive oxygen species that is induced during DENV infection. A six-hour treatment with 1 mM hydrogen peroxide reduced LRP-1 protein expression (Fig. [3A](#Fig3){ref-type="fig"}). We also tested if treatment of Aag2 cells with lipid-depleted media reduced intracellular cholesterol concentration after 1, 2, and 3 days. Intracellular cholesterol concentration was significantly reduced 2 and 3 days post treatment (Fig. [3B](#Fig3){ref-type="fig"}). A three-day treatment with lipid-depleted media reduced LRP-1 expression (Fig. [3C](#Fig3){ref-type="fig"}). These data support that cellular stimuli that occur during flavivirus infection can reduce LRP-1 protein expression.Figure 3Diverse cellular stimuli reduce LRP-1 protein expression. (**A**) Western blot analysis of LRP-1 and actin in Aag2 cell lysates treated for six-hours with 1 mM hydrogen peroxide. (**B**) Cholesterol content was determined in Aag2 cells treated with complete (**C**) and lipid-depleted (LD) media 1, 2, and 3 dpt. The experiment was performed in triplicate and Student's t tests were performed between groups to assess statistical significance. (**C**) Western blot analysis of LRP-1 and actin in Aag2 cells treated for three days with lipid-depleted media.

We then determined if DENV infection creates a cellular environment that would mimic lipid depletion by quantifying the cholesterol content in uninfected and infected cells each day during a 1-week time course. We found that DENV infection limited intracellular cholesterol accumulation similar to our treatment with lipid-depleted media (Figs [3C](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). These data reveal that DENV infection reduces cholesterol accumulation in mosquito cells, which is a stimulus that can reduce LRP-1 protein expression.Figure 4Cholesterol content in uninfected and infected cells. Cholesterol content was determined in mock (circles) and DENV-infected (squares) Aag2 cells each day for seven days. The experiment was performed in triplicate and Student's t tests were performed between groups to assess statistical significance.

LRP-1 decreases intracellular cholesterol content and inhibits DENV replication {#Sec14}
-------------------------------------------------------------------------------

One function of LRP-1 is to limit the concentration of intracellular cholesterol^[@CR18],[@CR21],[@CR23]--[@CR25]^. We hypothesized DENV reduces LRP-1 protein expression to maintain intracellular cholesterol levels, which facilitates virus replication. In order to test this hypothesis, we transfected Aag2 cells with control or LRP-1 dsRNA and confirmed gene knockdown by qRT-PCR (Fig. [5A](#Fig5){ref-type="fig"}). We then transfected Aag2 cells with control or LRP-1 dsRNA, and then inoculated cells with DENV2. We assessed intracellular cholesterol content and total viral RNA 24 hours post infection (hpi). LRP-1 knockdown significantly increased intracellular cholesterol levels (Fig. [5B](#Fig5){ref-type="fig"}). Further, LRP-1 knockdown significantly increased total viral RNA levels (Fig. [5C](#Fig5){ref-type="fig"}). These data suggest that LRP-1 knockdown promotes intracellular cholesterol accumulation and that this correlates with increased virus replication.Figure 5LRP-1 knockdown increases intracellular cholesterol and DENV viral RNA. (**A**) Total cellular RNA was extracted from Aag2 cells 24 hours after being either transfected with GFP dsRNA, or transfected with LRP1 dsRNA. A no dsRNA control was included. qRT-PCR was performed to determine LRP-1 gene expression and normalized to actin gene expression. (**B**,**C**) Aag2 cells were transfected with GFP or LRP-1 dsRNA. A no dsRNA control was included. Cells were then either Mock or DENV2-infected 24 hpt. (**B**) Cholesterol content was determined 24 hpi. (**C**) qRT-PCR was performed to determine intracellular DENV2 vRNA levels 24 hpi. Each experiment was performed in triplicate and Student's t tests were performed between groups to assess statistical significance.

We confirmed that intracellular cholesterol is important for DENV infection by growing Aag2 cells in both complete and lipid-depleted media for 7 days. Cells grown in lipid-depleted media had significantly less intracellular cholesterol (Fig. [6A](#Fig6){ref-type="fig"}). Both control and lipid-depleted cells were inoculated with DENV in complete media, unbound virus was removed, and complete media was replaced onto the cells. A focus forming unit assay was performed 3 dpi and a statistically significant decrease in virus replication was observed on the lipid-depleted cells (Fig. [6B,C](#Fig6){ref-type="fig"}). These data confirm that intracellular cholesterol facilitates DENV infection.Figure 6Lipid depletion reduces DENV infection. (**A**) Cholesterol content was determined in Aag2 cells treated with complete (**C**) and lipid-depleted (LD) media 7 dpt. (**B**) Aag2 cells treated with complete or lipid-depleted media for 7 days were inoculated with DENV2 in complete media for 1 hr. Unbound virus was removed and complete media was added for 3 days. Cells were fixed and DENV2-positive foci were revealed used DENV2-specific antibody. Foci were quantified in each well. Mock-infected controls were included. (**C**) Representative 20x images of the focus forming unit assay are shown. Experiments were performed in triplicate and Student's t tests were performed between groups to assess statistical significance.

Aag2 cells grow in lipid-depleted media {#Sec15}
---------------------------------------

Our data suggest that DENV reduces LRP-1 protein expression in order to maintain intracellular cholesterol to facilitate its replication; however, we also found that Aag2 cells reduce LRP-1 protein expression when treated with lipid-depleted media (Fig. [3B,C](#Fig3){ref-type="fig"}). It is possible lipid depletion is also harmful to the cell, and that both the virus and the cell benefit by reducing LRP-1 protein expression. To test this hypothesis, we determined the growth kinetics of uninfected and infected Aag2 cells in the presence of complete and lipid-depleted media. We found that Aag2 cells grown in lipid-depleted media had a marginal growth disadvantage that was not statistically significant and that the growth kinetics did not change during infection (Fig. [7A,B](#Fig7){ref-type="fig"}). These data suggest that a reduction in host-derived intracellular lipids do not significantly impact cell growth.Figure 7Aag2 cells grow with lipid-depleted media and during DENV2 infection. Cell growth of Aag2 cells was determined each day for 7 days in (**A**) complete and (**B**) lipid-depleted media. Cells were Mock (circles) or DENV2-infected (squares).

Discussion {#Sec16}
==========

DENV is one of the most important vector-borne human diseases, and has the potential to spread due to changes in climate and movement of humans and animals^[@CR38]^. Few effective options are available to combat the spread of this disease. New or improved control strategies are needed^[@CR3]^. There is increasing interest in the molecular mechanisms of DENV replication in its mosquito vector as a prophylactic or therapeutic target because of proof-of-principle studies showing that it is theoretically possible to target vector proteins or pathways that interfere with acquisition and transmission of vector-borne diseases^[@CR3]--[@CR11],[@CR39]--[@CR41]^.

A number of recent studies have shown the importance of cholesterol homeostasis during DENV replication in *Ae. aegypti*^[@CR42]--[@CR47]^. For instance, *Wolbachia* infection perturbs intracellular cholesterol and vesicular trafficking and leads to inhibition of virus replication^[@CR47]^. Further, altering cholesterol distribution by modifying expression of sterol carrier protein 2 inhibited DENV infection^[@CR42]^. Our laboratory found that human low-density lipoprotein inhibits flavivirus infection *in vitro* and *in vivo*^[@CR46]^. It is clear that DENV is dependent on cholesterol itself or lipid sorting pathways in the mosquito.

Cholesterol dependence is curious given that *Ae. aegypti* is a cholesterol auxotroph; although, this lipid is readily available in each blood meal^[@CR48]^. Aag2 cells and the midgut epithelium are able to take up human LDL via clathrin-mediated endocytosis^[@CR46]^. Cholesterol uptake appears to benefit oogenesis, although our current data suggests that providing cell with lipid-depleted media only marginally reduces cell growth rate^[@CR48]^. *Ae. aegypti* cells are able to synthesize their own lipids from protein and sugar, so host lipids are likely not required for growth of somatic cells.

The current study identified extracellular fragments of *Ae. aegypti* LRP-1 that were only present during DENV2 infection. We confirmed that LRP-1 protein expression is reduced during infection, and during stimuli that occur during virus infection such as exposure to reactive oxygen species and changes in cholesterol concentration. Additional research is required to determine if the level of stimulus is equal during virus infection. DENV2 infection also limited cholesterol accumulation, which either occurred by promoting shedding of intracellular cholesterol or preventing cholesterol uptake.

LRP-1 has been identified as a factor that reduces accumulation of intracellular cholesterol^[@CR17],[@CR18],[@CR21]--[@CR25]^. We hypothesized that this function of LRP-1 would have an antiviral effect. We confirmed this hypothesis by performing RNAi and showed that LRP-1 knockdown increased both intracellular cholesterol content and DENV2 vRNA. We also showed that depletion of host lipids from Aag2 cells reduced DENV2 infection. A caveat to our study is that we have not directly linked the extracellular peptides that were identified by LC + MS/MS to RIP, which would require more research into structural alteration of Aedes aegypti LRP-1 during physiological stimuli and identification of enzymes responsible for its proteolytic cleavage. Unfortunately, the enzymes identified in vertebrate systems are not evolutionarily conserved in mosquitoes. Further research is required to understand the details of RIP in mosquito cells.

These data provide support that LRP-1 functions to reduce host-derived intracellular cholesterol content, and that DENV2 replication is enhanced when cholesterol levels are increased. Our data suggest that multiple stimuli that are present during virus infection can reduce LRP-1 protein expression and that this may be due to RIP. Future studies will reveal the molecular pathways that *Ae. aegypti* use to acquire and maintain host lipids and how these pathways benefit flaviviruses during acquisition and transmission.
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